Accessibility: Skip to content

Machine learning and artificial intelligence are in the middle of hype in various fields of science.

Medaffcon has been working with RWE data since the Biobank Act took effect in 2013, studying the status of various patient groups in a real world setting. Watch the video below to see our vision on how machine learning and AI methods could be applied to (Finnish) RWE data improving personalized patient care.

RWE data possesses huge potential to improve patient care, and machine learning could be the tool to utilize this potential now and in the future.
– Iiro Toppila, Biostatistician, Medaffcon Oy


Read more on this topic from our previous post.

Previous section:

Next section:
Kehittyvä terveydenhuolto